HIRERIGHT ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of HRT and Encourages Investors to Contact the Firm
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of HireRight Holdings Corp. (NYSE: HRT) (“HireRight”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by General Atlantic, L.P. and Stone Point Capital LLC (“Sponsors”).
Click here to learn more and participate in the action.
On February 16, 2024, HireRight announced that it had entered into an agreement to be acquired by the Sponsors in a $1.65 billion all-cash deal. Pursuant to the merger agreement, the Sponsors will acquire all of the outstanding shares they do not already own for $14.35 per share in cash. The deal is expected to close by mid-2024.
Bragar Eagel & Squire is concerned that HireRight’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for HireRight’s stockholders.
If you own shares of HireRight and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Brandon Walker by email at investigations@bespc.com or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker , Esq.
walker@bespc.com
www.bespc.com
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth